|
|
Prepublished online as a Blood First Edition Paper on February 13, 2003; DOI 10.1182/blood-2002-09-2991.
Submitted October 1, 2002
Accepted February 4, 2003
Performance- and safety-enhanced lentiviral vectors containing the human interferon- scaffold attachment region and the chicken -globin insulator
Ali Ramezani, Teresa S Hawley, and Robert G Hawley*
Hematopoiesis Department, American Red Cross Holland Laboratory, Rockville, MD, USA
Hematopoiesis Department, American Red Cross Holland Laboratory, Rockville, MD, USA; Flow Cytometry Facility, American Red Cross Holland Laboratory, Rockville, MD, USA
Hematopoiesis Department, American Red Cross Holland Laboratory, Rockville, MD, USA; Blood and Cell Therapy Development, American Red Cross Holland Laboratory, Rockville, MD, USA; Department of Anatomy and Cell Biology, and Programs in Genetics and Molecular and Cellular Oncology, The George Washington University, Washington, DC, USA
* Corresponding author; email: hawleyr{at}usa.redcross.org.
Retroviral vectors are the most efficient means of stable gene delivery to hematopoietic stem cells (HSCs). However, transgene expression from retroviral vectors is frequently subject to the negative influence of chromosomal sequences flanking the site of integration. Toward the development of autonomous transgene expression cassettes, we inserted the human interferon- scaffold attachment region (IFN-SAR) and the chicken -globin 5'HS4 insulator separately and together into a series of self-inactivating (SIN) lentiviral vector backbones. Transduced cells of the human CD34+ hematopoietic progenitor line KG1a - pooled populations as well as individual clones harboring single integrants - were analyzed for reporter expression during culture periods of up to 4 months. Vectors carrying both the 5'HS4 insulator and the IFN-SAR consistently outperformed control vectors without inserts as well as vectors carrying either element alone. The performance of a set of vectors containing the murine stem cell virus long terminal repeat as an internal promoter was subsequently assessed during in vitro monocytic differentiation of transduced primary human CD34+ cord blood cells. Similar to what was observed in the KG1a hematopoietic progenitor cell model, optimal reporter expression in primary monocytes was obtained with the vector bearing both regulatory elements. These findings indicate that the 5'HS4/IFN-SAR combination is particularly effective at maintaining open chromatin domains permissive for high-level transgene expression at early and late stages of hematopoietic development, and thus could be of utility in HSC-directed retroviral vector-mediated gene transfer applications.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
B. Y. Ryu, M. V. Evans-Galea, J. T. Gray, D. M. Bodine, D. A. Persons, and A. W. Nienhuis
An experimental system for the evaluation of retroviral vector design to diminish the risk for proto-oncogene activation
Blood,
February 15, 2008;
111(4):
1866 - 1875.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. S. Vieyra and M. A. Goodell
Pluripotentiality and Conditional Transgene Regulation in Human Embryonic Stem Cells Expressing Insulated Tetracycline-ON Transactivator
Stem Cells,
October 1, 2007;
25(10):
2559 - 2566.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. C. Cheng, K. M. Sakamoto, E. M. Horwitz, S. L. Karsten, L. Shoemaker, H. I. Kornblumc, and P. Malik
Report on the Workshop "New Technologies in Stem Cell Research," Society for Pediatric Research, San Francisco, California, April 29, 2006
Stem Cells,
April 1, 2007;
25(4):
1070 - 1088.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Y. Zhou, Z. Ye, G. Chen, Z. P. Gao, Y. A. Zhang, and L. Cheng
Inducible and Reversible Transgene Expression in Human Stem Cells After Efficient and Stable Gene Transfer
Stem Cells,
March 1, 2007;
25(3):
779 - 789.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Van Damme, L. Thorrez, L. Ma, H. Vandenburgh, J. Eyckmans, F. Dell'Accio, C. De Bari, F. Luyten, D. Lillicrap, D. Collen, et al.
Efficient Lentiviral Transduction and Improved Engraftment of Human Bone Marrow Mesenchymal Cells
Stem Cells,
April 1, 2006;
24(4):
896 - 907.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. He, Q. Yang, and L.-J. Chang
Dynamic DNA Methylation and Histone Modifications Contribute to Lentiviral Transgene Silencing in Murine Embryonic Carcinoma Cells
J. Virol.,
November 1, 2005;
79(21):
13497 - 13508.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. S. Akimov, A. Ramezani, T. S. Hawley, and R. G. Hawley
Bypass of Senescence, Immortalization, and Transformation of Human Hematopoietic Progenitor Cells
Stem Cells,
September 1, 2005;
23(9):
1423 - 1433.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Malik and P. I. Arumugam
Gene Therapy for {beta}-Thalassemia
Hematology,
January 1, 2005;
2005(1):
45 - 50.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Puthenveetil, J. Scholes, D. Carbonell, N. Qureshi, P. Xia, L. Zeng, S. Li, Y. Yu, A. L Hiti, J.-K. Yee, et al.
Successful correction of the human {beta}-thalassemia major phenotype using a lentiviral vector
Blood,
December 1, 2004;
104(12):
3445 - 3453.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Kurre, J. Morris, B. Thomasson, D. B. Kohn, and H.-P. Kiem
Scaffold attachment region-containing retrovirus vectors improve long-term proviral expression after transplantation of GFP-modified CD34+ baboon repopulating cells
Blood,
November 1, 2003;
102(9):
3117 - 3119.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. F. Atweh, J. DeSimone, Y. Saunthararajah, H. Fathallah, R. S. Weinberg, R. L. Nagel, M. E. Fabry, and R. J. Adams
Hemoglobinopathies
Hematology,
January 1, 2003;
2003(1):
14 - 39.
[Abstract]
[Full Text]
[PDF]
|
|
|
| |
